Our Presence

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said a further two people from a group of hard-to-treat melanoma patients in its SCOPE study have responded to its drug regimen, taking the number to 11 out of 13, or an objective response rate…

Based out of London, Leucid Bio is a pioneering biotech company working on next-generation cell therapies for hard-to-treat cancers. Recently, the company announced that it secured £11.5 million in a Series A funding round.

PH startup CloudEats bags $5m from Vulpes, Gobi Partners

Vulpes Ventures was named one of the most active investors in Vietnam’s startups by Tech in Asia

Singapore-based digital mental health company ThoughtFull has raised $4 million in a pre-Series A funding round led by Sheares Healthcare Group, a healthcare-focused investment entity under Temasek. The round was also joined by Vulpes Investment Management, The Hive Southeast Asia,…

Steve Diggle, co-founder of volatility hedge fund Artradis Fund Management, which scored a $2.7 billion trading gain between 2007 and 2008, is sitting on the sidelines this time as bank woes rock markets.